186 related articles for article (PubMed ID: 18803262)
21. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
22. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
[TBL] [Abstract][Full Text] [Related]
23. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW
Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956
[TBL] [Abstract][Full Text] [Related]
24. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
[TBL] [Abstract][Full Text] [Related]
25. Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells.
Fimmel S; Saborowski A; Orfanos CE; Zouboulis CC
Horm Res; 2000; 54(5-6):306-11. PubMed ID: 11595823
[TBL] [Abstract][Full Text] [Related]
26. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
27. Telomerase inhibition, oligonucleotides, and clinical trials.
Corey DR
Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
[TBL] [Abstract][Full Text] [Related]
28. The development of telomerase inhibitors: the G-quartet approach.
Mergny JL; Mailliet P; Lavelle F; Riou JF; Laoui A; Hélène C
Anticancer Drug Des; 1999 Aug; 14(4):327-39. PubMed ID: 10625925
[TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
Tao M; Miyano-Kurosaki N; Takai K; Takaku H
FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
[TBL] [Abstract][Full Text] [Related]
30. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
31. Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
Schindler A; Fiedler U; Meye A; Schmidt U; Füssel S; Pilarsky C; Herrmann J; Wirth MP
Int J Oncol; 2001 Jul; 19(1):25-30. PubMed ID: 11408918
[TBL] [Abstract][Full Text] [Related]
32. [Antisense oligodeoxynucleotides of human telomerase reverse transcriptase inhibit endometrial carcinoma cell HEC-1A proliferation].
Chen XJ; Zheng W; Wang SQ
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):212-5. PubMed ID: 12839678
[TBL] [Abstract][Full Text] [Related]
33. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.
Simberg D; Weisman S; Talmon Y; Barenholz Y
Crit Rev Ther Drug Carrier Syst; 2004; 21(4):257-317. PubMed ID: 15638468
[TBL] [Abstract][Full Text] [Related]
34. In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung.
Fletcher S; Ahmad A; Perouzel E; Heron A; Miller AD; Jorgensen MR
J Med Chem; 2006 Jan; 49(1):349-57. PubMed ID: 16392819
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Hus1 by antisense oligonucleotides enhances the sensitivity of human lung carcinoma cells to cisplatin.
Kinzel B; Hall J; Natt F; Weiler J; Cohen D
Cancer; 2002 Mar; 94(6):1808-14. PubMed ID: 11920544
[TBL] [Abstract][Full Text] [Related]
37. Telomerase as an anti-cancer target: current status and future prospects.
Neidle S; Kelland LR
Anticancer Drug Des; 1999 Aug; 14(4):341-7. PubMed ID: 10625926
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human telomerase by 2'-O-methyl-RNA.
Pitts AE; Corey DR
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11549-54. PubMed ID: 9751703
[TBL] [Abstract][Full Text] [Related]
39. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
40. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
